Current Medicinal Chemistry
Title:Editorial: Bioactive Substances from Medicinal Plants for Metabolic Disorders
Volume: 24 Issue: 4
Author(s): Branca M. Silva, Pedro F. Oliveira, Marco G. Alves and Tania R. Dias
Affiliation:
Export Options
About this article
Cite this article as:
Silva M. Branca, Oliveira F. Pedro, Alves G. Marco and Dias R. Tania, Editorial: Bioactive Substances from Medicinal Plants for Metabolic Disorders, Current Medicinal Chemistry 2017; 24 (4) . https://dx.doi.org/10.2174/092986732404170302223350
DOI https://dx.doi.org/10.2174/092986732404170302223350 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
Current Vascular Pharmacology Non-Communicable Diseases and Adherence to Mediterranean Diet
Endocrine, Metabolic & Immune Disorders - Drug Targets Is there a Role for Oral Triple Therapy in Patients with Acute Coronary Syndromes Without Atrial Fibrillation?
Current Vascular Pharmacology Nesfatin/Nucleobindin-2 (NUCB2) and Glucose Homeostasis
Current Hypertension Reviews Biomarkers of Protein Oxidation in Human Disease
Current Molecular Medicine Role of Islet-, Gut-, and Adipocyte-Derived Hormones in the Central Control of Food Intake and Body Weight: Implications for an Integrated Neurohormonal Approach to Obesity Pharmacotherapy
Current Diabetes Reviews Transforming Growth Factor-Beta and the Kidney: What We Know and What We Can Do?
Current Enzyme Inhibition Macrovascular Protecting Effects of Berberine through Anti-inflammation and Intervention of BKCa in Type 2 Diabetes Mellitus Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Is there a Relationship Between Gestational Diabetes and Postpartum Depression?
Current Women`s Health Reviews A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure
Current Vascular Pharmacology Ferritin and Percent Transferrin Saturation Levels Predict Type 2 Diabetes Risk and Cardiovascular Disease Outcomes
Current Diabetes Reviews Recent Patents on Oral Insulin
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Structures Required of Polyphenols for Inhibiting Advanced Glycation end Products Formation
Current Drug Metabolism Biology of Protooncogene c-kit Receptor and Spermatogenesis
Current Pharmacogenomics Lipid Metabolism in Patients with End-Stage Renal Disease: A Five Year Follow-up Study
Current Vascular Pharmacology Applications of Umbilical Cord Derived Mesenchymal Stem Cells in Autoimmune and Immunological Disorders: From Literature to Clinical Practice
Current Stem Cell Research & Therapy Inhibition of Protein Tyrosine Phosphatase 1B as a Potential Treatment of Diabetes and Obesity
Current Pharmaceutical Design In Vitro and In Vivo Profiles and Characterization of Insulin Nanocarriers Based in Flexible Liposomes Designed for Oral Administration
Letters in Drug Design & Discovery Pathophysiology of Type 2 Diabetes in Children and Adolescents
Current Diabetes Reviews Healing the Diabetic Heart: Modulation of Cardiometabolic Syndrome through Peroxisome Proliferator Activated Receptors (PPARs)
Current Molecular Pharmacology